ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 平成28年度 厚生労働科学研究の概要 > 中間・事後評価委員会名簿 > 慢性の痛み政策研究事業

慢性の痛み政策研究事業 中間・事後評価委員名簿

(○:委員長)

糸山泰人 国際医療福祉大学 副学長
神経内科学
〈研究論文〉

Fujihara K, Misu T, Nakashima I, Takahashi T, Bradl M, Lassmann H,Takano T, Nishiyama S, Takai I, Suzuki C, Sato D, Kuroda H, Nakamura M, Fujimori J, Narikawa K, Sato S, Itoyama Y, Aoki M: Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease. Clin Exp Neuroimmunol 3:58-73, 2012
〈研究論文〉

Kuroda H, Fujihara K, Takano R, Takai Y, Takahashi T, Misu T, Nakashima I, Sato S, Itoyama Y, Aoki M:Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica. J Neuroimmunol. 15:254(1-2):178-82, 2013
〈研究論文〉

Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M: Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 11:80(24):2210-6. 2013
 
菊地 臣一 公立大学法人福島県立医科大学理事長兼学長
整形外科学
Low Testosterone Levels and Reduced Kidney Function in Japanese Adult Men: The Locomotive Syndrome and Health Outcome in Aizu Cohort Study.
Kurita N, Horie S, Yamazaki S, Otani K, Sekiguchi M, Onishi Y, Takegami M, Ono R, Konno S, Kikuchi S, Fukuhara S.
J Am Med Dir Assoc. 17(4):371.e1-6,2016
Prevalence and Location of Neuropathic Pain in Lumbar Spinal Disorders: Analysis of 1,804 Consecutive Patients with Primary Lower Back Pain.
Orita S, Yamashita T, Ohtori S, Yonenobu K, Kawakami M, Taguchi T, Kikuchi SI, Ushida T, Konno SI, Nakamura M, Fujino K, Matsuda S, Yone K, Takahashi K.
Spine .41(15):1224-1231,2016

Relationship between Kyphotic Posture and Falls in Community-Dwelling Men And Women: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study.
Tominaga R, Fukuma S, Yamazaki S, Sekiguchi M, Otani K, Kikuchi SI, Sasaki S, Kobayashi S, Fukuhara S, Konno SI.
Spine 41(15):1232-1238,2016
 
武田雅俊 藍野大学・学長
専門分野 精神医学
The AKT1 gene is associated with attention and brain morphology in schizophrenia. Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Nemoto K, Ohnishi T, Yamamori H, Takahashi H, Iike N, Kamino K, Yoshida T, Azechi M, Ikezawa K, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Iwase M, Kazui H, Takeda M. World J Biol Psychiatry. 2013 Mar;14(2):100-13.
Frequency diversity of posterior oscillatory activity in human revealed by spatial filtered MEG. Ishii R, Canuet L, Aoki Y, Ikeda S, Hata M, Takahashi H, Nakahachi T, Gunji A, Iwase M, Takeda M. J Integr Neurosci. 2013 Sep;12(3):343-53.
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Ikeda M, Okahisa Y, Aleksic B, Won M, Kondo N, Naruse N, Aoyama-Uehara K, Sora I, Iyo M, Hashimoto R, Kawamura Y, Nishida N, Miyagawa T, Takeda M, Sasaki T, Tokunaga K, Ozaki N, Ujike H, Iwata N. Neuropsychopharmacology. 2013 Sep;38(10):1864-70.
 
宮坂 信之 東京医科歯科大学名誉教授
内科学(膠原病)、臨床免疫学
Yoshihashi-Nakazato Y, Kawahata K, Kimura N, Miyasaka N, Kohsaka H. Interferon-y, but not interleukin-4, suppresses experimental polymyositis. Arthritis Rheumatol.、68(6):1505-1510, 2016
Tanaka Y, Takeuchi T, Miyasaka N, Sumida T, Mimori T, Koike T, Endo K, Mashino N, Yamamoto K. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy. Mod. Rheumatol. 26(1):80-86, 2016

ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 平成28年度 厚生労働科学研究の概要 > 中間・事後評価委員会名簿 > 慢性の痛み政策研究事業

ページの先頭へ戻る